AVEO/Astellas Terminate Agreement
moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
AVEO
5:31 am AVEO Pharma and Astellas (ALPMY) to end worldwide collaboration & license agreement for development and commercialization of Tivozanib; Phase 2 Colorectal Cancer Study discontinued
moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
5:31 am AVEO Pharma and Astellas (ALPMY) to end worldwide collaboration & license agreement for development and commercialization of Tivozanib; Phase 2 Colorectal Cancer Study discontinued
moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Financial
moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
Aveo, Astellas end pact to develop cancer drug Tivozanib
[Reuters] – Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo’s lead experimental drug and said they would discontinue a mid-stage study testing its use in colon cancer. Aveo said in January it would end a mid-stage t moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view […]
AVEO and Astellas to End Worldwide Collaboration & License Agreement for Development and Commercialization of Tivozanib
[Business Wire] – CAMBRIDGE, Mass. & TOKYO–(BUSINESSWIRE)– AVEO Oncology (NASDAQ:AVEO – News) and Astellas Pharma Inc. (TSE:4503) today announced the companies will end their worldwide collaboration and license agreement for the development and commerc moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
Tracking Seth Klarman’s Baupost Group Holdings – Q4 2013 Update
moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
AVEO and Astellas Report Final Overall Survival Results from TIVO-1
[Business Wire] – CAMBRIDGE, Mass. & TOKYO–(BUSINESSWIRE)– AVEO Oncology (NASDAQ:AVEO) and Astellas Pharma Inc. (TSE:4503) today announced overall survival (OS) for tivozanib, an investigational agent, from the Phase … moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
AVEO and Astellas Announce Initiation of Patient Enrollment in Phase 2 Trial of Tivozanib inCombination with Paclitaxel in Patients with Advanced Triple Negative Breast Cancer
[at noodls] – BATON-BC Trial Initiation Marks Entry into Third Tumor Type for Tivozanib Clinical Development Program CAMBRIDGE, Mass. and TOKYO, Japan, December 3, 2012 – AVEO Oncology (NASDAQ:AVEO) and Astellas Pharma … moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
AVEO and Astellas Announce Initiation of Patient Enrollment in Phase 2 Trial of Tivozanib in Combination with Paclitaxel in Patients with Advanced Triple Negative Breast Cancer
[Business Wire] – CAMBRIDGE, Mass. & TOKYO–(BUSINESSWIRE)– AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced the initiation of patient enrollment in a randomized, double-blind, multicenter … moreView todays social media effects on AVEOView the latest stocks trending across Twitter. Click to view dashboardSee who AVEO is hiring next, click here to view […]
